Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling-Reference-Cited by-同舟云学术

Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling

Published:2012 Issue:2 Volume:51 Page:77-83
ISSN:0912-0009
Container-title:Journal of Clinical Biochemistry and Nutrition
language:en
Short-container-title:J. Clin. Biochem. Nutr.

Author:

Lee Jeong-Sang,Cho Ji-Yoon,Song Heup,Kim Eun-Hee,Hahm Ki-Baik

Publisher

The Society for Free Radical Research Japan

Subject

Clinical Biochemistry,Nutrition and Dietetics,Medicine (miscellaneous)

Reference29 articles.

1. 1 Saukkonen K, Rintahaka J, Sivula A, et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003; 111: 915–925.

2. Structure, Regulation and Function of NF-kappaB

3. Activator Protein-1 Transcription Factor Mediates Bombesin-stimulated Cyclooxygenase-2 Expression in Intestinal Epithelial Cells

4. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells

5. 5 Xie J, Qian J, Wang S, Freeman ME, 3rd, Epstein J, Yi Q. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J Immunol 2003; 171: 4792–4800.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of vonoprazan pyrazole derivatives as potential reversible inhibitors of gastric proton pump: An in silico molecular docking study;Acta Facultatis Medicae Naissensis;2024

2. Potassium-competitive Acid Blockers: A New Therapeutic Strategy for Helicobacter pylori Eradication;The Korean Journal of Helicobacter and Upper Gastrointestinal Research;2023-09-15

3. Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis;Gut and Liver;2023-02-15

4. Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy;Cellular Oncology;2022-09-23

5. Review article: potassium‐competitive acid blockers for the treatment of acid‐related disorders;Alimentary Pharmacology & Therapeutics;2021-02-16